Skip to main content

The Worldwide Poultry Vaccines Industry is Expected to Reach $2.47 Billion by 2027 - ResearchAndMarkets.com

The "Poultry Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.

The global poultry vaccines market reached a value of US$ 1.67 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 2.47 Billion by 2027, exhibiting at a CAGR of 6.59% during 2022-2027.

Companies Mentioned

  • AniCon Labor GmbH (SAN Group)
  • Biovac Ltd.
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Elanco
  • Hester Biosciences Limited
  • Merck & Co. Inc.
  • Phibro Animal Health Corporation
  • Venkys India
  • Zoetis Inc.

Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Poultry disease is an infectious animal disease affecting poultry species, such as duck, chicken, turkey, and goose. It causes facial edema, diarrhea, twisting of neck and paralysis of wings and legs, cyanosis of comb, reduction in egg production, and sudden death.

As a result, poultry animals undergo vaccination to stimulate their immune mechanism and produce antibodies, which inactivates pathogens. The vaccination also assists in preserving the productive health of these animals by acting as a protective measure against the outbreak of contagious diseases. At present, it can be administered via injections, feed, eye-drop, and drinking water.

There is currently an increase in the prevalence of zoonotic diseases like avian influenza or bird flu that spreads among animals and infects humans. This, along with the escalating demand for animal health diagnostics, represents one of the key factors strengthening the growth of the market.

Apart from this, the increasing consumption of animal-derived products and rising concerns about food safety around the world are contributing to market growth. Furthermore, leading market players are considerably investing in research and development (R&D) activities to introduce poultry vaccines that help protect against avian diseases, such as infectious bronchitis, infectious bursal diseases, and virulent Newcastle disease (VND).

They are also utilizing advanced technologies to manufacture effective vaccines, which is creating a favorable market outlook. Besides this, the growing awareness among veterinary practitioners about animal vaccination is positively influencing the market. Other major factors, including a significant rise in the spending on animal health worldwide, an increase in the poultry population, and the introduction of live, non-replicating recombinant antigens, nucleic acid-mediated, and live-gene detected vaccines, are projected to drive the market.

Key Questions Answered in This Report:

  • How has the global poultry vaccines market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global poultry vaccines market?
  • What are the key regional markets?
  • What is the breakup of the market based on the disease?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the dosage form?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global poultry vaccines market and who are the key players?
  • What is the degree of competition in the industry?

Key Topics Covered:

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

4.1 Overview

4.2 Key Industry Trends

5 Global Poultry Vaccines Market

5.1 Market Overview

5.2 Market Performance

5.3 Impact of COVID-19

5.4 Market Forecast

6 Market Breakup by Disease

7 Market Breakup by Product

8 Market Breakup by Dosage Form

9 Market Breakup by Application

10 Market Breakup by End User

11 Market Breakup by Region

12 SWOT Analysis

13 Value Chain Analysis

14 Porters Five Forces Analysis

15 Price Analysis

16 Competitive Landscape

16.1 Market Structure

16.2 Key Players

16.3 Profiles of Key Players

For more information about this report visit https://www.researchandmarkets.com/r/veqknm

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.